Drugs / ToleroMune Ragweed
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01361412 | Mar → Sep 2011 | ragweed sensitivity | Circassia Limited | Completed | No outcome recorded |
| Phase 2 | NCT01198613 | Sep 2010 → Aug 2011 | ragweed sensitivity | Circassia Limited | Completed | No outcome recorded |
| Phase 2 | NCT00878774 | Apr → Nov 2009 | ragweed sensitivity | Circassia Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ToleroMune Ragweed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01361412 ↗ |
| Modality | Vaccine | “synthetic, allergen-derived peptide desensitising vaccine” NCT00878774 ↗ |